about
A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data.Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3).The development and utilisation of the European Organisation for research and treatment of cancer quality of life group item bank.Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.Health care providers underestimate symptom intensities of cancer patients: a multicenter European study.Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.Psychological distress in head and neck cancer patients 7-11 years after curative treatment.A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients.Quality of life in head and neck cancer patients after surgical resection: translation into Cantonese and validation of the EORTC QLQ-H&N35.Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review.International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.Improved treatment decisions in patients with esophageal cancer.Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy.Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial.Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients.Radical treatment for oesophageal cancer patients unfit for surgery and chemotherapy. A 10-year experience from the Norwegian Radium Hospital.Prevalence rates for and predictors of self-reported adherence of oncology outpatients with analgesic medications.[Tumour-modifying therapy].Quality of life and head and neck cancer: a 5 year prospective study.The relationship between hope and pain in a sample of hospitalized oncology patients.Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy.The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients.Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence.Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy.Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer.Demographic, clinical, and pain characteristics are associated with average pain severity groups in a sample of oncology outpatients.Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study.The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life.The relationships between mood disturbances and pain, hope, and quality of life in hospitalized cancer patients with pain on regularly scheduled opioid analgesic.Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.Health-related quality of life during the last three months of life in patients with advanced cancer.Prognostic factors in patients with nasopharyngeal carcinoma.Characteristics and implications of attrition in health-related quality of life studies in palliative care.A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy.Making Advances in Quality of Life Studies in Head and Neck Cancer.Prospective, Longitudinal Quality-of-Life Study of Patients With Head and Neck Cancer: A Feasibility Study Including the EORTC QLQ-C30.The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group.The relationships between demographic and clinical characteristics and quality of life during and after radiotherapy: in women with breast cancer.
P50
Q30661130-F2AA864F-6AD1-4E01-BF12-C60108FE591AQ31956856-4C935965-8FB9-4ECE-9F25-E2E88BC3BC6FQ33445127-AD8D48C5-FE82-462D-A9A8-47FFB03358F6Q33495456-076523B2-E67C-499F-BA7E-302604BE0585Q34174412-DD9631EB-1275-4CF3-8C9D-0E478AD34422Q34792547-BCDA78AB-8C09-4600-A99E-62753BCC9A74Q35644151-C0FF2215-7527-404B-8A8F-665D242A7A94Q36080540-72F97463-F87B-4E08-B418-81F708FEF532Q36617789-C456BDB8-F4C6-4EA3-B58A-290E4477489CQ37259368-1D54CFF5-06F4-4167-A114-807ADBB937E4Q38063344-06A265AD-CF6E-40CB-BD64-F378A4283936Q38393256-86D7DB3C-3B69-46CE-A224-92C152A3E8F4Q38689433-E0D365BC-35E6-4440-A2B4-2A0D3CC06A96Q39193497-AD55DBD4-DE65-4846-88D7-18B2BE29E87CQ39227935-31088150-21CE-461F-87F2-FA15FE9AE63DQ39252627-E7E6C8C5-2EC2-4F33-AF00-0E88BF0AF346Q39295486-E52EF1FE-A031-4775-B43F-8B1129883F0AQ39315567-313BD109-0580-4C77-AEB2-E6723899D461Q39354371-D7042A5A-82C7-4D28-A57E-7F52997C64F4Q39357551-9E4ECC5F-EF27-445D-AC5B-4A5A61F6945CQ40028201-97339DCD-F506-4965-B4E5-4F2E27AB7AF4Q40098364-A8B69715-655C-477C-B6C7-A29F0C7B1E4FQ40280700-FA000083-3874-4306-8965-12B23FB92C5AQ40385545-EF59D9E5-7049-4850-B1EB-EEB6B474544CQ41040742-B28D20DD-5EA7-44C8-B1D7-C7ECE6477AD2Q42670548-D2F504FC-0BD0-43FB-8A52-CB129E067A4EQ43485541-0D85173B-82DB-4174-8BD4-B6C1A19A759AQ43838693-D4FC18DD-F16C-4CDA-9E50-56E301566BC8Q44193209-8087BA0D-B3F3-4696-8E6E-9164552839DBQ44272137-1CA896F1-25B8-4864-97B8-3EE87703308BQ44349850-09C3176E-BD41-480C-B90F-F8EAA2779CD3Q44425822-7E0EB4A1-0D88-4487-A667-4896616A4FEDQ44518063-585130D4-9B79-4615-B61D-72840084622FQ44711624-819AE92E-ADC7-47F9-AD1B-ADC64C11D288Q45994258-A0E2F450-79BA-408D-A977-D2C973D5DDE3Q46449441-88E2BEBE-F36A-4590-8F0A-5B9281F55745Q47572866-C4C7F363-274D-4709-AB0D-6A0142F64D3AQ47639568-B8335776-FAA3-44A0-A564-A068454B0A9AQ47760136-81B7557B-4626-4ECB-9931-8B14584CB21CQ48072691-33D1E4FB-BD01-409F-A0FB-2621753FD802
P50
description
Noors onderzoekster
@nl
hulumtuese
@sq
norsk forsker
@nb
researcher
@en
հետազոտող
@hy
name
K Bjordal
@ast
K Bjordal
@es
K Bjordal
@nl
K Bjordal
@sl
Kristin Bjordal
@en
Kristin Bjordal
@nb
type
label
K Bjordal
@ast
K Bjordal
@es
K Bjordal
@nl
K Bjordal
@sl
Kristin Bjordal
@en
Kristin Bjordal
@nb
prefLabel
K Bjordal
@ast
K Bjordal
@es
K Bjordal
@nl
K Bjordal
@sl
Kristin Bjordal
@en
Kristin Bjordal
@nb
P106
P21
P27
P31
P496
0000-0002-1914-494X